An additional case with a malignant OAN in this series (case 2) had evidence of mismatch repair deficiency on immunohistochemistry (loss of MSH2 and MSH6 expression) but no pathogenic germline or somatic variant was identified. Here, MSH6 is linked to mismatch repair cancer syndrome 1.